WO2019080848A1 - 抹竹及其制备方法和用途 - Google Patents
抹竹及其制备方法和用途Info
- Publication number
- WO2019080848A1 WO2019080848A1 PCT/CN2018/111523 CN2018111523W WO2019080848A1 WO 2019080848 A1 WO2019080848 A1 WO 2019080848A1 CN 2018111523 W CN2018111523 W CN 2018111523W WO 2019080848 A1 WO2019080848 A1 WO 2019080848A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bamboo
- rags
- leaves
- color
- matcha
- Prior art date
Links
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims abstract description 262
- 235000017491 Bambusa tulda Nutrition 0.000 title claims abstract description 262
- 241001330002 Bambuseae Species 0.000 title claims abstract description 262
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims abstract description 262
- 239000011425 bamboo Substances 0.000 title claims abstract description 260
- 239000000843 powder Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 206010033546 Pallor Diseases 0.000 claims abstract description 40
- 239000002994 raw material Substances 0.000 claims abstract description 40
- 235000013305 food Nutrition 0.000 claims abstract description 34
- 238000001035 drying Methods 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 31
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 27
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 17
- NNBFNNNWANBMTI-UHFFFAOYSA-M brilliant green Chemical compound OS([O-])(=O)=O.C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 NNBFNNNWANBMTI-UHFFFAOYSA-M 0.000 claims abstract description 16
- 238000000227 grinding Methods 0.000 claims abstract description 16
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920005610 lignin Polymers 0.000 claims abstract description 14
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 9
- 229960005305 adenosine Drugs 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 claims abstract description 7
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 claims abstract description 7
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 claims abstract description 7
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 claims abstract description 7
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims abstract description 7
- 241001330024 Bambusoideae Species 0.000 claims abstract description 6
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 claims abstract description 6
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 63
- 238000010298 pulverizing process Methods 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 42
- 239000002245 particle Substances 0.000 claims description 41
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000007864 aqueous solution Substances 0.000 claims description 23
- 206010022489 Insulin Resistance Diseases 0.000 claims description 21
- 102000004877 Insulin Human genes 0.000 claims description 20
- 108090001061 Insulin Proteins 0.000 claims description 20
- 229940125396 insulin Drugs 0.000 claims description 20
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 19
- 244000302661 Phyllostachys pubescens Species 0.000 claims description 18
- 235000003570 Phyllostachys pubescens Nutrition 0.000 claims description 18
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 16
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 16
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 14
- 230000000968 intestinal effect Effects 0.000 claims description 13
- 239000011670 zinc gluconate Substances 0.000 claims description 13
- 235000011478 zinc gluconate Nutrition 0.000 claims description 13
- 229960000306 zinc gluconate Drugs 0.000 claims description 13
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 13
- -1 isovite Chemical compound 0.000 claims description 12
- 229960001763 zinc sulfate Drugs 0.000 claims description 11
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 11
- 238000000498 ball milling Methods 0.000 claims description 9
- 235000010755 mineral Nutrition 0.000 claims description 8
- 241001087135 Phyllostachys meyeri Species 0.000 claims description 7
- 244000182751 Bothriochloa bladhii Species 0.000 claims description 6
- 241001654555 Indocalamus decorus Species 0.000 claims description 6
- 244000061322 Nicotiana alata Species 0.000 claims description 6
- 208000001132 Osteoporosis Diseases 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- 241000177203 Sarocalamus faberi Species 0.000 claims description 6
- 241000544458 Sasa tsuboiana Species 0.000 claims description 6
- 241001497774 Yushania Species 0.000 claims description 6
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 6
- 238000007602 hot air drying Methods 0.000 claims description 6
- 229910052726 zirconium Inorganic materials 0.000 claims description 6
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 claims description 5
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 claims description 5
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 5
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 claims description 5
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 4
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 4
- 206010010774 Constipation Diseases 0.000 claims description 4
- 229930186217 Glycolipid Natural products 0.000 claims description 4
- 241000267025 Pleioblastus kongosanensis Species 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 4
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 4
- 230000007661 gastrointestinal function Effects 0.000 claims description 4
- 238000010902 jet-milling Methods 0.000 claims description 4
- 230000004060 metabolic process Effects 0.000 claims description 4
- 230000004089 microcirculation Effects 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims description 4
- 240000005827 Phyllostachys nigra Species 0.000 claims description 3
- 235000010717 Phyllostachys nigra Nutrition 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 241000579895 Chlorostilbon Species 0.000 claims description 2
- 230000001934 delay Effects 0.000 claims description 2
- 229910052876 emerald Inorganic materials 0.000 claims description 2
- 239000010976 emerald Substances 0.000 claims description 2
- 239000001056 green pigment Substances 0.000 claims description 2
- 230000001502 supplementing effect Effects 0.000 claims description 2
- 241000959403 Pleioblastus amarus Species 0.000 claims 2
- 230000037149 energy metabolism Effects 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 abstract 2
- ODBRNZZJSYPIDI-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-6-C-glucopyranosylflavone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-UHFFFAOYSA-N 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 abstract 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 abstract 1
- WJJFWGUVMIUWGG-UHFFFAOYSA-N Stereolensin Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O WJJFWGUVMIUWGG-UHFFFAOYSA-N 0.000 abstract 1
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 abstract 1
- ODBRNZZJSYPIDI-VJXVFPJBSA-N isoorientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-VJXVFPJBSA-N 0.000 abstract 1
- UYJGIAWJIRZBNU-UHFFFAOYSA-N isoorientin Natural products OCC1OC(C(O)C(O)C1O)c2cc(O)c(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4 UYJGIAWJIRZBNU-UHFFFAOYSA-N 0.000 abstract 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 abstract 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 abstract 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 abstract 1
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 81
- 230000000694 effects Effects 0.000 description 47
- 238000012360 testing method Methods 0.000 description 42
- 235000019197 fats Nutrition 0.000 description 38
- 244000269722 Thea sinensis Species 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 35
- 239000008280 blood Substances 0.000 description 35
- 240000004971 Pseudosasa japonica Species 0.000 description 27
- 239000000523 sample Substances 0.000 description 27
- 235000013616 tea Nutrition 0.000 description 27
- 239000000047 product Substances 0.000 description 25
- 235000009200 high fat diet Nutrition 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 230000001953 sensory effect Effects 0.000 description 21
- 235000013618 yogurt Nutrition 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 19
- 229930002875 chlorophyll Natural products 0.000 description 18
- 235000019804 chlorophyll Nutrition 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 14
- 235000015145 nougat Nutrition 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 240000004153 Hibiscus sabdariffa Species 0.000 description 12
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 12
- 235000005291 Rumex acetosa Nutrition 0.000 description 12
- 229930003935 flavonoid Natural products 0.000 description 12
- 235000017173 flavonoids Nutrition 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 235000003513 sheep sorrel Nutrition 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 150000002215 flavonoids Chemical class 0.000 description 11
- 235000009569 green tea Nutrition 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- 238000013116 obese mouse model Methods 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 210000000577 adipose tissue Anatomy 0.000 description 10
- 235000021196 dietary intervention Nutrition 0.000 description 10
- 230000002757 inflammatory effect Effects 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 102000011690 Adiponectin Human genes 0.000 description 9
- 108010076365 Adiponectin Proteins 0.000 description 9
- 108010028554 LDL Cholesterol Proteins 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- 230000037356 lipid metabolism Effects 0.000 description 9
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 235000013824 polyphenols Nutrition 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000014510 cooky Nutrition 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 201000010063 epididymitis Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000021588 free fatty acids Nutrition 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 108010023302 HDL Cholesterol Proteins 0.000 description 7
- 102000016267 Leptin Human genes 0.000 description 7
- 108010092277 Leptin Proteins 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 230000018044 dehydration Effects 0.000 description 7
- 238000006297 dehydration reaction Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 229940039781 leptin Drugs 0.000 description 7
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 6
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 6
- 235000020332 matcha tea Nutrition 0.000 description 6
- 230000036542 oxidative stress Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000004575 stone Substances 0.000 description 6
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000605059 Bacteroidetes Species 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000192125 Firmicutes Species 0.000 description 5
- 229920002488 Hemicellulose Polymers 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 235000011194 food seasoning agent Nutrition 0.000 description 5
- 238000007446 glucose tolerance test Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000447 pesticide residue Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 239000003642 reactive oxygen metabolite Substances 0.000 description 5
- 235000015067 sauces Nutrition 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 4
- 241001156739 Actinobacteria <phylum> Species 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 241000192142 Proteobacteria Species 0.000 description 4
- 240000008510 Sundacarpus amarus Species 0.000 description 4
- 241001261005 Verrucomicrobia Species 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000014121 butter Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000012149 noodles Nutrition 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 235000019587 texture Nutrition 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000004889 Interleukin-6 Human genes 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 241000011500 Phyllostachys praecox Species 0.000 description 3
- 235000008545 Phyllostachys praecox Nutrition 0.000 description 3
- 241000600085 Phyllostachys sulphurea Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000219995 Wisteria Species 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000019219 chocolate Nutrition 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- 238000012165 high-throughput sequencing Methods 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229940100601 interleukin-6 Drugs 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 150000007965 phenolic acids Chemical class 0.000 description 3
- 235000009048 phenolic acids Nutrition 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 150000008130 triterpenoid saponins Chemical class 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000209128 Bambusa Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 2
- 102000019034 Chemokines Human genes 0.000 description 2
- 108010012236 Chemokines Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000283070 Equus zebra Species 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 208000002705 Glucose Intolerance Diseases 0.000 description 2
- 240000003553 Leptospermum scoparium Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 240000001857 Phyllostachys elegans Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004032 porphyrins Chemical group 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 201000009104 prediabetes syndrome Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001007 puffing effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000011506 response to oxidative stress Effects 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- MSLKMRUEVOYOOZ-VBYMZDBQSA-L 519-62-0 Chemical compound [Mg+2].[N-]1C2=C(C=3[C@H]([C@H](C)C(=CC=4C(=C(C=C)C(=C5)N=4)C)N=3)CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H](C(=O)OC)C([O-])=C2C(C)=C1C=C1C(CC)=C(C=O)C5=N1 MSLKMRUEVOYOOZ-VBYMZDBQSA-L 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000282452 Ailuropoda melanoleuca Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000000173 Camellia sinensis var sinensis Nutrition 0.000 description 1
- 241000372691 Candidatus Saccharibacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 241001143296 Deferribacteres <phylum> Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- HDPISCIDKUMRDI-UHFFFAOYSA-M N(=O)[O-].[Na+].[N+](=O)([O-])[O-].[Al+3] Chemical compound N(=O)[O-].[Na+].[N+](=O)([O-])[O-].[Al+3] HDPISCIDKUMRDI-UHFFFAOYSA-M 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000566145 Otus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000131694 Tenericutes Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 235000012438 extruded product Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000021070 high sugar diet Nutrition 0.000 description 1
- 238000013238 high-fat diet model Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/02—Dehydrating; Subsequent reconstitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/06—Blanching
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/154—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/157—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
- A23C9/1548—Non-dried milk gels, creams or semi-solid products obtained by heating milk with a sugar without using gums, e.g. milk jam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
- A23L3/3508—Organic compounds containing oxygen containing carboxyl groups
- A23L3/3517—Carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/54—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution using irradiation or electrical treatment, e.g. ultrasonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
- A23P10/47—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added using additives, e.g. emulsifiers, wetting agents or dust-binding agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Definitions
- the present invention relates to the field of natural products, food materials, functional ingredients and dietary supplements. More specifically, it relates to a rag bamboo product and a preparation method and use thereof.
- the tea powder on the market is mainly divided into two categories, namely matcha and green tea powder.
- the prices vary greatly and the quality is uneven.
- Matcha is a kind of ultrafine powder made by a series of special processing processes such as shading, steaming and stone grinding.
- the average particle size is generally 800-1000 mesh, with green color and refreshing seaweed. aroma. Brew with a certain amount of hot water and whipped it thoroughly.
- the tea soup is green and has a white foam on the surface, and the tea is overflowing.
- the reason why Matcha has such excellent quality thanks to its unique raw materials and processing methods, the entire production process needs to go through: tea tree shading, tender bud picking, steaming, cooling, baking, screening, stone grinding and so on. Among them, shading treatment is one of the key steps in the production of matcha.
- the shading treatment of tea leaves with one bud and two leaves increases the content of chlorophyll and amino acids in the leaves, and reduces the polyphenols and caffeine content of heavier astringency. .
- Grinding method is another key factor in the production of matcha. Due to the unstable green and aroma of the tea leaves, the increase in heat generated by high-speed shearing during pulverization significantly affects the color and flavor of the matcha. Therefore, stone grinding is conventionally used to maintain low-speed and low-temperature to minimize the loss of flavor.
- Matcha polished with high-quality graphite from Japan is said to have a fineness of more than 5,000 mesh, and it is said that it can be directly absorbed through the skin.
- ultra-fine green tea powder refers to green tea powder prepared by ultra-fine pulverization of fresh tea leaves after high-temperature greening and dehydration drying.
- the preparation process comprises: blade picking, high temperature killing (usually using steam inactivation enzyme), hydrazine, dehydration drying, ultrafine pulverization, etc., wherein there is no shading process of tea tree, and the pulverizing method adopts more efficient mechanical pulverization, and the product is generally granulated.
- the diameter is between 500 and 800 mesh, and the sensory qualities such as color, aroma and fineness cannot be compared with matcha. Therefore, there are significant differences between the two types of matcha and green tea powder, and their market prices are also very different.
- bamboo forest is a natural companion to tea gardens, and the requirements for climate and soil micro-ecology are almost identical.
- China is known as the "kingdom of bamboo”.
- China's existing bamboo forest area is 90.15 million mu, mainly distributed in the Yangtze River Basin and southern provinces, including Fujian, Zhejiang, Jiangxi, Hunan and Sichuan.
- the output value of the bamboo industry reached 192.3 billion yuan, and it has developed into a dynamic and potential emerging industry from resource cultivation, processing and utilization to export trade to bamboo forest eco-tourism.
- the national treasure giant panda relies on bamboo forest for a living, and bamboo leaves are one of its important food sources.
- bamboo leaves contain a large number of biologically active substances beneficial to the human body, such as: flavonoids, phenolic acids, terpenoids, polysaccharides, adenosine, and trace elements and minerals such as organic germanium, silicone, etc., which can fight free radicals and antioxidants. , anti-fatigue, enhance immunity, regulate lipid metabolism and prevent cardiovascular and cerebrovascular diseases. China and Southeast Asia have had the habit of eating bamboo leaves since ancient times.
- bamboo leaf porridge, heatstroke should be used For example, “July Golden Moon” contains “July bamboo leaf porridge, heatstroke should be used”; “Materia Medica”: “Bamboo leaves, cool heart and spleen, Clear and thirst.”
- bamboo leaf antioxidants extracted from bamboo leaves have been included in the national standard GB 2760 as a food additive in 2004, and bamboo leaf flavonoids were also approved by the Chinese government as “new food ingredients” in 2013. At present, there are several kinds of bamboo leaf original tea and instant health tea developed from bamboo leaves.
- the so-called “bamboo leaf powder” or “light bamboo leaf powder” seen on the market are all extracts of bamboo leaves, generally water extracts.
- the basic method is: dry bamboo leaves with water (liquid to liquid ratio 1:10-15) ), hot reflux extraction, extract concentrated under reduced pressure, then add dextrin and other fillers, spray drying to obtain a powder (particle size is generally less than 300 mesh), its color can vary from light yellow to tan depending on the amount of filler It is slightly bitter and slightly scented with a certain fragrance of bamboo leaves. Its main purpose is to serve as a functional ingredient for health care products, food or drinks.
- the technical problem to be solved by the present invention is to provide a shovel (Matzhu or Matzoo), a preparation method thereof and a use thereof, and provide a new functional raw material, ingredients and dietary supplement components for the food and health care products industry. .
- the present invention provides a rag, which is prepared from the leaves of Graminae and Bambusoideae plants, has a stable emerald color, and has an average particle size.
- the diameter is between 800 and 10,000 mesh (ie, D 50 is 18.0-1.3 ⁇ m); the total dietary fiber is ⁇ 60%, the lignin content is ⁇ 20%, the mineral is ⁇ 7%; and at least three or more bamboo leaves are included.
- the characteristic components of the bamboo leaves are valerin, isoquercetin, vitexin, isovite, adenosine, ⁇ -hydroxylysine, p-coumaric acid.
- the stable emerald green color means that the color value of the rags is between 46 and 60, and ⁇ a* is between -16 and -8.
- the stable emerald green color means that after the rags are baked at a high temperature of 180 ° C for 30 min, the L* of the color value is still maintained between 40 and 50, and ⁇ a* is still at -7 ⁇ . Between 5
- the stable emerald green color means that the ⁇ a* of the color value of the rags after the ultraviolet irradiation for 180 minutes is still between -6 and -3.
- the stable emerald green color means that the color value is between 47 and 59, and ⁇ a* is between -15 and -9.
- the measurement and definition of the color value in the present invention adopts the L*, a*, b* chromaticity system of the International Commission on Illumination (CIE), which is most widely used for measuring the color tone of an object, and uses all the colors in a stereoscopic representation of a uniform color.
- CIE International Commission on Illumination
- *, a*, b* are defined by the coordinates of the three axes.
- L* indicates the brightness of the sample, where 0 is black and 100 is white; a* indicates the red-green direction of the sample, "+" is red, "-” is green; b* is blue-yellow, "+” It is yellow and the "-” value is blue.
- the value of ⁇ a indicates the difference between the a* value of the sample and the reference point, which better indicates the deviation of the sample from the red-green value of the standard white.
- the raw material source is Phyllostachys nigra var. Hnonis (Bean) Stepf ex Rendle, Zhejiang Phyllostachys meyeri McClure, Phyllostachys heterocycla var. pubescens (Mazel) Ohwi, and N. affinis ( Rendle)Keng f.), B.intermedia Hsueh et Yi, Yushania Keng f., P.amarus (keng Keng f.), B.fangiana Keng f.et Wen), fresh leaves of Pleioblastus kongosanensis f. aureostriaus, Sasa tsuboiana and Indocalamus decorus.
- the raw material source is Phylostachys nigra var. Hnonis (Bean) Stepf ex Rendle, Zhejiang Phyllostachys meyeri McClure, N. affinis (Rendle) Keng f., and M. bamboo (B.intermedia) Hsueh et Yi), Yushania Keng f., P. amarus (keng Keng f.), B.fangiana Keng f.et Wen, Sasa tsuboiana and Fresh leaves of the beautiful Indocalamus decorus.
- the invention also provides the preparation method of the above rags: the raw materials are sequentially subjected to blanching, color protection, drying and ultrafine pulverization; and the kiln having an average particle diameter of 800 to 10,000 is obtained;
- the raw material is a leaf of a plant of Graminae or Bambusoideae;
- the step of blanching and protecting the color is: placing the bamboo leaf as a raw material into a color protection liquid having a temperature of 80 to 100 ° C, immersing, removing and draining;
- the color protection liquid used in the blanching color protection is a zinc sulfate aqueous solution or a zinc gluconate aqueous solution having a concentration of 0.5 to 2.0 g/100 mL or a combination thereof.
- the step of blanching and protecting the color is: placing the bamboo leaf as a raw material into a color protection liquid having a temperature of 85 to 95 ° C, immersing for 30 to 90 seconds, removing and draining;
- the ratio of material to liquid of bamboo leaves and color protection liquid is 1g: 50 ⁇ 100mL;
- the color protection liquid used in the blanching color protection is a zinc sulfate aqueous solution or a zinc gluconate aqueous solution or a combination thereof having a concentration of 0.5 to 2.0 g/100 mL, and the color protection mechanism is to convert the originally unstable chlorophyll magnesium salt into Stable chlorophyll zinc salt maintains the chlorophyll's steady state and super-stable state, thus keeping the phoenix powder bright green.
- the color protection liquid used in the blanching color protection is a zinc sulfate aqueous solution or a zinc gluconate aqueous solution having a concentration of 0.5 g/100 mL or a combination thereof.
- the preparation process may further include photoelectric color selection and metal detection steps;
- the drying is: drying the leaves after the blanching and color treatment to a water content of ⁇ 11%;
- the drying is at least one of hot air drying, microwave drying, vacuum drying, freeze drying, or a combination thereof.
- the leaves after the blanching treatment are further dried to a moisture content of ⁇ 10% before the ultrafine pulverization.
- the leaves after the blanching treatment are further dried to a moisture content of ⁇ 7% before the ultrafine pulverization.
- the leaves after the blanching treatment are further dried to a moisture content of ⁇ 5% before the ultrafine pulverization.
- the raw material source is Phyllostachys nigra var. Hnonis (Bean) Stepf ex Rendle, Zhejiang Phyllostachys meyeri McClure, Phyllostachys heterocycla var. pubescens (Mazel) Ohwi, and N. affinis ( Rendle)Keng f.), B.intermedia Hsueh et Yi, Yushania Keng f., P.amarus (keng Keng f.), B.fangiana Keng f.et Wen), fresh leaves of Pleioblastus kongosanensis f. aureostriaus, Sasa tsuboiana and Indocalamus decorus.
- the raw material source is Phylostachys nigra var. Hnonis (Bean) Stepf ex Rendle, Zhejiang Phyllostachys meyeri McClure, N. affinis (Rendle) Keng f., and M. bamboo (B.intermedia) Hsueh et Yi), Yushania Keng f., P. amarus (keng Keng f.), B.fangiana Keng f.et Wen, Sasa tsuboiana and beautiful Fresh leaves of Indocalamus decorus.
- the ultrafine pulverization is to pulverize the dried leaves to an average particle diameter of 800 to 10,000 mesh.
- the ultrafine pulverization pulverizes the dried leaves to an average particle diameter of 1,000 to 3,000 mesh.
- the ultrafine pulverization pulverizes the dried leaves to an average particle diameter of 1,500 to 2,000 mesh.
- the ultrafine pulverization is performed by high-energy nano-impact ball milling, and the grinding ball is selected from zirconium balls, and the ball-to-batch ratio is 10:1;
- the ultrafine pulverization may also be performed by jet milling
- the ultrafine pulverization may also be performed by jet milling + high energy nano impact ball milling.
- the ball is made of zirconium ball, the ball-to-batch ratio is 10:1 (w/w); the ultra-finely pulverized sample is a piece of 0.5-1.0 cm in diameter, pulverized for 1-8 hours, average The particle size is from 800 to 10,000 mesh.
- the preparation process is specifically: using bamboo leaves as raw materials for blanching and color protection, and the color protection liquid adopts 0.5-2.0 g/100 mL of zinc sulfate aqueous solution or zinc gluconate aqueous solution or a combination thereof, and the ratio of material to liquid is 1 g: 50 to 100 mL, the bamboo leaves as raw materials are placed in a color protection liquid at a temperature of 85 to 95 ° C, and the blanching time is 30 to 90 sec; the bamboo leaves after the blanching and color treatment are dried to a moisture content of ⁇ 11%.
- the nano-impact mill is pulverized, or pulverized to about 300 mesh by a jet mill, and then pulverized by a high-energy nano-impact mill.
- the ball-to-batch ratio is 10:1, and the pulverization time is 1-8 h, and the average particle diameter is 800-10,000. Purpose smear products.
- the more preferable preparation process is specifically: using bamboo leaves as raw materials, the color protection liquid adopts 1.5 g/100 mL (1.5%, w/v) zinc gluconate aqueous solution, the ratio of material to liquid is 1 g: 80 mL, and the bamboo leaves are placed in the temperature.
- the color protection liquid 85-95 ° C
- the blanching time is 60 sec; the leaves after the blanching and color-protecting treatment are dried at 80 ⁇ 1 ° C until the moisture content is about 10%; and the crusher is cut into 0.5-1.0 cm.
- Tablets color selection to remove leaf trays and yellow zebra leaves; further microwave sterilization for sterilization and dehydration, so that the moisture content is reduced to 5% or less; pulverized to about 300 mesh with a jet mill, and then pulverized with a high-energy nano-impact mill,
- the ball-to-material ratio was 10:1 (w/w), and the pulverization time was 1.5 hours, and the kiln having an average particle diameter of 2,000 mesh was obtained.
- chlorophyll is the main substance of bamboo leaf color, including chlorophyll a and chlorophyll b.
- Chlorophyll is a magnesium porphyrin compound, its chemical properties are extremely unstable, light, acid, alkali, oxygen, oxidant, etc. will decompose and discolor. For example, under acidic conditions, chlorophyll molecules can easily lose magnesium in the porphyrin ring to become brown. Demagnesium chlorophyll.
- the ratio of chlorophyll to pheophytin was positively correlated with the quality of bamboo leaves.
- the green protection method commonly used in fruit and vegetable processing is to replace Mg 2+ with Zn 2+ , Cu 2+ , Fe 2+ , Ca 2+ , etc. to form stable chlorophyll zinc, copper, iron, calcium and other compounds, so that green save.
- a suitable blanching treatment time of 80 to 100 ° C (more preferably 85 to 95 ° C) is 30 to 60 sec, and the obtained blade has the brightest color. And green; if the blanching time is too long (such as 120sec and above), not only the leaf color is significantly lighter, but also the significant decrease in the content of active ingredients (such as flavonoids, phenolic acids, triterpenoids, etc.) can be detected.
- the extraction of the leaves of different color retention times clearly shows that the extracts of the 30 sec and 60 sec samples of the blanching treatment are very dark, while the green color of the extract treated for 120 sec is significantly lighter.
- the leaves treated with such color protection and the obtained rags are bright and green, have excellent light stability and thermal stability, and have excellent color stability.
- the preparation method of the rags bamboo of the present invention first, a green, ecological, non-polluting natural bamboo forest is selected, and fresh leaves are picked to obtain raw materials having low heavy metal content and almost zero agricultural residues; the raw material pretreatment includes Finishing, cleaning and cleaning of fresh bamboo leaves; the process of blanching and color protection is: putting the pretreated raw bamboo leaves into a color protection liquid with a temperature of 85-95 ° C, the concentration of the color protection liquid is 0.5-2.0 g /100mL of zinc sulphate aqueous solution or zinc gluconate aqueous solution or a combination thereof, control blanching time between 30 ⁇ 90s (liquid to liquid ratio of 1g: 50 ⁇ 100mL), and then remove and drain; the drying process is: Drying and bleaching the leaves after drying (may be hot air drying, microwave drying, vacuum drying or vacuum freeze drying) to a water content of ⁇ 11%; after breaking to pieces of 0.5 to 1.0 cm, color selection removes leaf and yellow spots Leave
- the ultrafine pulverization adopts a high-energy nano-impact grinding
- the grinding ball uses a zirconium ball
- the ball-to-material ratio is 10:1 (w/w)
- the injection material is a piece having a diameter of 0.5 to 1.0 cm
- the pulverization treatment After 1 to 2 hours, the average particle size can reach 1,000 mesh or more.
- the material can be pulverized to 100-500 mesh in advance with a conventional ball mill or jet mill.
- the color protection liquid adopts 1.5 g/100 mL (1.5%, w/v) zinc gluconate aqueous solution, and the ratio of material to liquid is 1 g: 80 mL, heat
- the hot time is 60 sec; the leaves after blanching and color treatment are dried at 80 ⁇ 1 ° C until the moisture content is about 10.0%; the pieces are cut into 0.5-1.0 cm pieces by a crusher, and the leaves and yellow zebra leaves are removed by color selection;
- Microwave drying is used for sterilization and dehydration to reduce the moisture content to 5% or less; it is pulverized to about 300 mesh by a jet mill, and then pulverized by a high-energy nano-impact mill.
- the ball-to-batch ratio is 10:1 (w/w).
- the pulverization time was 4 hours, and the kiln having an average particle diameter of about 2,000 mesh was obtained.
- the invention also provides the use of the rags prepared by the above method: using the thermal stability and photostability of the bamboo as a food material, a functional ingredient, or as a dietary supplement;
- the added amount of rags is 1 to 10% (w/w), preferably 2 to 5% (w/w).
- Supplementing dietary fiber improving gastrointestinal function, helping to control weight and prevent constipation
- Strengthening natural leaf antioxidants such as flavonoids, p-coumaric acid, adenosine, and ⁇ -hydroxylysine can help improve microcirculation, regulate glycolipid metabolism, and effectively protect cardiovascular and cerebrovascular diseases;
- bamboo-specific ingredients such as silicone and organic bismuth, which helps prevent osteoporosis, keeps the skin young and delays the body's aging.
- the invention adopts fresh bamboo leaves as raw materials, adopts unique processing technology, and creates an ultra-fine powder with excellent green color, fragrant scent and uniform fineness, which is called rag bamboo, has the processing suitability and health effect close to matcha, and is human.
- the society provides a new type of food functional ingredient and/or dietary supplement that is natural, green, rich in bamboo leaf chemicals and dietary fiber.
- the razor bamboo has bright emerald green color, high thermal stability and light stability, and can be widely used in the food industry as a coloring agent, a thickener and a flavoring agent, such as a cake, a cookie, an ice cream, Chocolate, candy, and milk tea are especially advantageous in foods that require high-temperature processing (such as baking, frying, and puffing).
- rags can be used independently as a dietary supplement, as well as in pet food or livestock and aquaculture.
- the rags of the present invention is used as a natural source of food and a low energy density functional ingredient in various food systems.
- the content of heavy metals (lead, arsenic, mercury, cadmium, etc.) and pesticide residues of the bamboo of the present invention are significantly lower than that of Matcha.
- the rags of the present invention can obtain products with different particle size distributions by selecting different pulverizing equipments or combinations thereof and adjusting the process parameters of the pulverizing unit.
- the beneficial effects of the invention are prominently manifested in: firstly, according to the characteristics of bamboo leaf materials (high degree of fiber quality, active ingredients are not easily dissolved; color green, good thermal stability, etc.), using hot water blanching method, using zinc salt The solution is subjected to a replacement color protection treatment, that is, the unstable chlorophyll magnesium salt in the original leaf is converted into a highly stable chlorophyll zinc salt to maintain its green color. Secondly, based on the stability energy of the above raw materials, high-energy nano-impact grinding is used to achieve ultrafine pulverization of bamboo leaves, which greatly improves the production efficiency of the pulverizing section compared with the stone-grinding Matcha process.
- the high-strength zirconium ball used in the pulverization process can also ensure the entry of foreign matter in the rag bamboo (and it is difficult to avoid the stone powder entering the product during the stone grinding process).
- most of China's bamboo forests are natural or semi-natural forests, and pesticides and fertilizers are rarely used, which is conducive to the production of natural, green and non-polluting organic razor products.
- the rags of the present invention have the following specific uses:
- rag As a natural source of fibrous food and low energy density functional ingredients, rag can be used in solid, semi-solid, suspended foods, to supplement human dietary fiber, improve gastrointestinal function, etc. Helps prevent constipation and control weight.
- scented bamboo In view of the green appearance and scent of scented bamboo, it has good color stability. It can be used as a natural coloring agent, thickener and flavoring agent in food fields (such as cakes and cookies) where all matcha may be used. Ice cream, chocolate, candy, milk tea, coffee, etc., especially in high-temperature processed food systems (such as baking, frying, extruded products).
- Adding bamboo to a variety of foods in a certain proportion helps to improve and regulate the intestinal flora, improve the body's sensitivity to insulin, prevent insulin resistance, and prevent metabolic syndrome.
- the rags of the present invention can be independently used as a dietary supplement, and can also be applied to pet food or added to livestock and poultry and aquatic feed.
- the present invention has the following main advantages:
- the bamboo of the present invention has a total dietary fiber of >60%, a lignin content of >20%, and a mineral (ash) of >7%, both equal to or higher than Matcha; and at the same time, is rich in carbon flavonoids (Herba a functional component unique to bamboo leaves such as glycosides, isoquercetin, vitexin, isovite, adenosine, ⁇ -hydroxylysine, p-coumaric acid, organic hydrazine, and silicone.
- the sorrel of the present invention has a brighter green color than Matcha and has higher thermal stability and light stability.
- the rags remained substantially green within 30 min, while the matcha had browned significantly at 15 min.
- Due to its verdant, stable natural color, rags can be added directly as a natural pigment to a variety of solid, semi-solid and suspended foods that require coloration. For example, it is used in cakes, cookies, ice cream, chocolate, candy, milk tea, coffee, especially in foods that require high temperature processing (such as baking, frying, puffing). At the same time, it can also play a role in thickening and flavoring in the food system.
- bamboo can be used to supplement human body in various foods. Dietary fiber, improving gastrointestinal function, etc., help to control weight and prevent constipation; help to improve and regulate intestinal flora, improve the body's sensitivity to insulin, prevent insulin resistance, prevent metabolic syndrome; help Improve the human microcirculation, regulate sugar and lipid metabolism, effectively protect the heart and brain blood vessels; help prevent osteoporosis, keep the skin young and delay the body aging.
- rag bamboo has a level of heavy metals far lower than matcha, and almost no pesticide residue, is a substantially pure natural green organic food.
- special antibacterial components flavonoids, phenolic acids, etc.
- conventional nutrients such as proteins, amino acids, sugars, etc.
- bamboo forests in China are mainly distributed in old, small, border and poor areas.
- the invention of razor bamboo has opened up a new way for the high value conversion of bamboo resources. While providing high-quality food functional ingredients and dietary supplements for human society and promoting the construction of healthy China, it is also very helpful to the issue of “agriculture, rural areas and farmers”. The solution and the poverty alleviation of the poor will surely become a new economic growth point for the bamboo industry.
- Fig. 1 is a schematic view showing the reaction process of blanching and color protection according to the present invention.
- Figure 2 is a comparison of the particle sizes of the rags prepared in Examples 1.3, 1.5, and 1.6 and the commercially available Grade 1 Matcha;
- A is Mianzhu - rag,
- B bitter bamboo - rag,
- C cold arrow - wipe bamboo,
- D Matcha (Grade 1);
- A is dietary fiber
- B soluble dietary fiber C hemicellulose
- D lignin E coarse ash
- F moisture content
- Figure 4 is a sensory evaluation result of the rags and matcha prepared in Examples 1.5 and 1.6;
- Figure 5 is a graph showing the weight gain of mice with metabolic syndrome
- Figure 6 is a bar graph of the weight of some organs and tissues in the 12th week of metabolic syndrome mice; A is liver, B kidney, C spleen, D perirenal fat, E epididymal fat;
- Figure 7 shows changes in insulin sensitivity at 12 weeks in mice with metabolic syndrome; A is an insulin tolerance test (ITT) and B is a glucose tolerance test (GTT);
- ITT insulin tolerance test
- GTT glucose tolerance test
- Figure 8 is the level of inflammatory factors in the serum of mice with metabolic syndrome; the left panel is the TNF- ⁇ content map, and the right panel is the MCP-1 content map;
- Figure 9 is a liver H&E stained section of the mice with metabolic syndrome (400 ⁇ ), 50 ⁇ m; among them, A to E represent the normal group, high fat group, 2.5% bitter bamboo + high fat group, 5.0% bitter bamboo + high fat group, 2.5% cold arrow bamboo rag + high fat group, 2.5% matcha powder + high fat group;
- Figure 10 is a H&E stained section of adipose tissue in mice with metabolic syndrome (200 ⁇ ), 100 ⁇ m; among them, A to E represent normal group, high fat group, 2.5% bitter bamboo + high fat group, 5.0% bitter bamboo bamboo + high fat group, 2.5% cold arrow bamboo + bamboo high fat group, 2.5% matcha powder + high fat group;
- Figure 11 is a structural diagram of the intestinal flora of experimental mice with metabolic syndrome
- Figure 12 is a process flow diagram of cake making
- Figure 13 is a sensory evaluation of plain yogurt and three yogurts added with the same proportion of rags (Example 1.5) and Matcha;
- Figure 14 is a sensory evaluation of three nougat additions of rags, matcha and blanks as described in Example 1.5.
- the raw material of the invention preferably the fresh leaves with complete morphology, the old leaves, the yellow leaves, the worm leaves are removed, and the petioles are removed as much as possible; the bamboo core which has not been leaf-leaved is the best raw material, and the best smeared bamboo can be prepared.
- the rags according to the present invention are prepared from the leaves of Graminae and Bambusoideae plants, and have stable emerald green color, and the average particle diameter of the powder is 800-10,000 mesh (ie, D 50 is Between 18 and 1.3 ⁇ m); total dietary fiber ⁇ 60%, lignin content ⁇ 20%, mineral ⁇ 7%; and at least 3 or more bamboo leaf characteristic components; and at least 3 and above Characteristic of bamboo leaves;
- the characteristic components of the bamboo leaves are valerin, isoquercetin, vitexin, isovite, adenosine, ⁇ -hydroxylysine, p-coumaric acid.
- the stable emerald green color means that the color value of the rags is between 46 and 60, and ⁇ a* is between -16 and -8.
- the stable emerald green color means that after the rags are baked at a high temperature of 180 ° C for 30 min, the L* of the color value is still maintained between 40 and 50, and the ⁇ a* is still at -7 ⁇ . Between -5.
- the stable emerald green color means that after the ultraviolet ray is irradiated for 180 minutes, the ⁇ a* of the color value is still between -6 and -3.
- the stable emerald green color means that the color value is between 47 and 59, and ⁇ a* is between -15 and -9.
- the preparation method of rags is specifically as follows:
- the method may be hot air drying, microwave drying, vacuum drying, or even freeze drying, any one or a combination thereof.
- the pieces of ⁇ 1.0 cm are pulverized for 1 to 8 hours to obtain an ultrafine powder of rags with an average particle size of 800 to 10,000 mesh, bright green color, fragrant smell, and fineness.
- the pulverizing apparatus may be subjected to stepwise pulverization before the ultrafine pulverization, and the pulverizing apparatus may be any one or a combination of ball milling, stone grinding, high energy nano impact grinding, and jet mill.
- test methods used in the present invention are as follows:
- Experimental method first adjust the color difference meter to the whiteboard zero calibration, and then take a certain amount of rags sample on the standard whiteboard to evenly level the sample. Align the entrance of the colorimeter with the sample and click the test button to test.
- the portable colorimeter for food evaluation uses the L*, a*, b* chromaticity system of the International Commission on Illumination (CIE), which is most widely used to measure the color of objects, and all the stereoscopic representations of uniform colors.
- the color is defined by the coordinates of the three axes L*, a*, and b*.
- L* indicates the brightness of the sample, where 0 is black and 100 is white; a* indicates the red-green direction of the sample, "+” is red, "-” is green; b* is blue-yellow, "+” It is yellow and the "-” value is blue.
- the value of ⁇ a indicates the difference between the a* value of the sample and the reference point, which better indicates the deviation of the sample from the red-green value of the standard white.
- the sample was weighed in an appropriate amount, and 70% ethanol was added at a ratio of 1:20 to the liquid to be extracted by hot reflux at 90 ° C for 2 h.
- the extract was filtered to volume. Then, the flavonoid content in the extract was determined by the same method as described in the standard curve preparation, and then converted into the total flavonoid content of the bamboo.
- the sample was weighed in an appropriate amount, and 70% ethanol was added at a ratio of 1:20 to the liquid to be extracted by hot reflux at 90 ° C for 2 h.
- the extract was filtered to volume.
- the total phenolic content of the extract was then determined in the same manner as described in the standard curve fabrication and converted to the total phenolic content of the rag.
- the 20 mg arbutin standard was transferred into a small beaker, dissolved in 95% ethanol, and made up to 100 mL, and shaken to obtain a ursolic acid standard solution of 0.200 mg/mL.
- the color protection solution is a 1.5% (w/v) zinc gluconate aqueous solution, and the ratio of material to liquid is 1 g: 80 mL (w/v). According to the above ratio of material to liquid, cast a certain amount of fresh bamboo leaves to the slightly boiling color protection liquid (that is, the color protection liquid heated to 85-90 ° C), stir gently to spread the leaves evenly, and quickly remove them after 60 sec. dry;
- the dry leaves are cut into 0.5 ⁇ 1.0cm pieces by a crusher, and after removing the leaf leaves and the yellow spot leaves, the microwave drying is further used for sterilization and dehydration, so that the moisture content is reduced to 5% or less;
- the bamboo leaf is crushed to about 300 mesh by a jet mill, and then pulverized by a high-energy nano-impact mill (produced by Qinhuangdao Taiji Ring Nano-product Co., Ltd., model CJM-SY-B; the same below). 10:1 (w/w), ball milling time 1.0 h, to obtain an average particle size of about 900 mesh rags (recorded as: light bamboo - rag bamboo).
- the color protection liquid is a 0.5 g/100 mL (0.5%, w/v) zinc gluconate aqueous solution, and the ratio of the material to the liquid is 1 g: 80 mL (w/v).
- a slightly boiling color protection liquid that is, a color protection liquid heated to 85-90 ° C
- the dried leaves are broken into pieces of 0.5-1.0 cm, and the leaves are removed and the leaves are removed.
- the microwave drying is further used for sterilization and dehydration to reduce the moisture content to 5% or less;
- the dried bamboo leaves were pulverized with a high-energy nano-impact mill.
- the ball-to-batch ratio was 10:1 (w/w), and the ball milling time was 30 min.
- the kiln with an average particle size of about 900 mesh was obtained (recorded as: Cizhu-Matu).
- the color protection solution is a 1.0% (w/v) zinc sulfate aqueous solution, and the ratio of material to liquid is 1 g: 80 mL (w/v).
- a certain amount of bamboo leaves are added to the micro-boiling color protection liquid (that is, the color protection liquid heated to 85-95 ° C), the leaves are evenly dispersed by slight stirring, and quickly removed after 30 sec, drained. ;
- the bamboo shoots were treated with a high-energy nano-impact mill.
- the ratio of the ball to the material was 15:1 (w/w), and the pulverization time was 2 h.
- the kiln with an average particle size of about 2000 was obtained (recorded as: Mianzhu-Matu).
- the drained bamboo leaves are continuously treated with a belt type microwave drying equipment (Shanghai Yuanyue Light Industry Machinery Co., Ltd., model YTLD), the microwave power is 4Kw, the conveyor speed is about 0.5m/min, and the drying time is about 60. Minutes, get dry leaves with a moisture content of about 7%, use ordinary Chinese herbal medicine grinder to break them into pieces and keep them for use;
- a belt type microwave drying equipment Shanghai Yuanyue Light Industry Machinery Co., Ltd., model YTLD
- the pulverization treatment was carried out with a high-energy nano-impact mill, the ball-to-material ratio was 10:1 (w/w), and the pulverization time was 3 hours, and the kiln with an average particle diameter of about 8000 mesh was obtained (denoted as: bitter bamboo - rag bamboo).
- Product characteristics are shown in Table 5.
- the pulverization treatment was carried out with a high-energy nano-impact mill, the ball-to-material ratio was 10:1 (w/w), and the pulverization time was 2 hours, and the razor bamboo having an average particle diameter of about 10,000 was obtained (denoted as: cold arrow bamboo - rag bamboo).
- Preparation of sample solution Take a certain amount of rags, add 30% ethanol solution at a ratio of 1:20; then extract in a 70 °C water bath for 2 h; filter the extract, store in vacuum, and transfer to a 50 mL volumetric flask. The volume was dissolved in methanol. After storage at 4 ° C, the sample was filtered through a 0.22 ⁇ m microporous membrane before the sample was injected, and the filtrate was taken as the test solution for use.
- the method for determination of flavonoids of cucurbita (valerin, isoquercetin, vitexin, isovite) and p-coumaric acid is referred to the national standard "food additive bamboo leaf antioxidant" (GB 30615-2014).
- the chromatographic conditions were: C 18 ODS column (4.6 mm ⁇ 250 mm, 5 ⁇ m); mobile phase mixed solvent A (acetonitrile) and solvent B (volume fraction 0.2% acetic acid). Gradient elution conditions: 0-15min, A 15%, B 85%; 15-25min, A 15% ⁇ 40%, B 85% ⁇ 60%; 25 ⁇ 34min, A 40%, B 60%; 34 ⁇ 40min , A 40% to 15%, B 60% to 85%.
- the flow rate was 1.0 mL/min; the detection wavelength was 330 nm; the column temperature was 30 ° C; and the injection amount was 10 ⁇ L.
- ⁇ -hydroxylysine was determined by an automatic amino acid analyzer (Hitachi 835-50 high-speed amino acid automatic analyzer).
- the standard product was from Japan Wako Pure Chemical Industries Co., Ltd.; the determination of adenosine reference literature [Gong Jinyan et al., High Performance Liquid Chromatography The method is used to determine the content of adenosine in bamboo extract and its different parts, Food Industry 2014, 35 (12): 264-265, and the standard product is from China National Institute for the Control of Pharmaceutical and Biological Products.
- Figure 2 and Table 8 show that the particle size of the powder obtained by different bamboo species and different process parameters is significantly different.
- the average particle size of the four bamboo samples is smaller than that of the commercially available first-grade matcha sample.
- the contents of the conventional ingredients (including dietary fiber, soluble dietary fiber, hemicellulose, lignin, crude ash, and moisture) of the six rags samples and the control samples (primary matcha) in Example 1 were measured. According to the standard of GB 5009.88-2014, the content of dietary fiber and soluble dietary fiber is determined. The lignin content is determined according to the standard of GB/T 20805-2006. The moisture is determined according to the standard of GB/T 8304, and the total is determined according to the standard of GB/T 8306. Ash. The visual representation of the results is shown in Figure 3 and analyzed as follows.
- Total dietary fiber The dietary fiber content of 6 rags is between 63.0 and 80.2%, with an average of 76.1%. Among them, the lowest content is cold arrow bamboo - rag, the highest is Cizhu - rag bamboo; at the same time, the dietary fiber content of matcha is 63.9%; the total dietary fiber content of rag is higher than matcha.
- Soluble dietary fiber The soluble dietary fiber of 6 rags samples ranged from 28.2 to 33.6% with an average of 30.7%. Among them, the content of cold arrow bamboo - rag bamboo is the highest, Cizhu - rag bamboo is the lowest; the soluble dietary fiber content of Matcha is 31.8%, which falls within the variation range of rags.
- Hemicellulose The hemicellulose content of 6 rags samples ranged from 37.2 to 42.9%, the highest was sulphur-bamboo-sorrel, the lowest was bitter bamboo-sorrel; the half-cellulose content of matcha was 37.7%. It falls within the variation range of the rags sample.
- the lignin content of the six rags samples ranged from 23.0 to 25.4% with an average of 24.5%. Among them, the lignin content of bitter bamboo-wiat bamboo was the highest, and the sulphur-bamboo-sorry bamboo was the lowest; while the lignin content of matcha was only 13.3%; the lignin content of scented bamboo was significantly higher than matcha.
- Crude ash The coarse ash of 6 rags samples is between 8.1 and 11.9%, the highest content of cold arrow bamboo - rag bamboo, the lowest of Cizhu - rag bamboo; and the coarse ash content of matcha is only 5.7%, significantly lower than wipe bamboo.
- the total dietary fiber content, lignin and crude ash of the bamboo are significantly higher than the matcha.
- the content of soluble dietary fiber and hemicellulose of Matcha is not much different from that of the rags prepared in the above examples, and falls within the range of corresponding indicators of rag. This result is consistent with the fact that the degree of fibrosis of bamboo leaves is higher than that of tea leaves.
- the processing temperature commonly used for baking was 180 ° C for 5, 15, 30 min, and the same amount of samples were placed in each petri dish and placed in an oven for heat treatment.
- the results of the color difference analysis are summarized in Table 9.
- rags has better light stability than matcha, can be baked at 180 ° C for 30 minutes without browning, and at this time the green color of rags and the green at the beginning of the first matcha Close.
- Matcha changed from green to reddish brown after baking at 180 °C for 15 minutes.
- UV irradiation was used to observe the damage to the color of the sample.
- Three samples were simultaneously irradiated with 10 8w UV lamps, and the sample was placed 30 cm below the tube. Color difference analysis was performed after 60, 120, and 180 minutes of irradiation, respectively. The color value changes are shown in Table 10.
- the sensory evaluator statistically analyzed the scores of the three samples (mean ⁇ standard error), and the results are shown in FIG. 4 .
- the highest score of the two samples was bitter bamboo - sorrel, followed by cold arrow bamboo - rag, and matcha scored the lowest. From the scores of the four indicators, the bamboo is significantly higher in the shape and the color of the soup than the matcha, and the scores on the taste and the powder aroma are similar. Because ragatta has a more green color than Matcha, it is loved by the evaluators.
- the chlorophyll is decomposed by heat, and the tea soup quickly appears yellowish brown, so the score is lower than that of the bamboo; while the green color of the bamboo is stable, and the soup color can remain green for a long time after brewing.
- Example 3 Comparison of biological health effects of smut and matcha
- Metabolic syndrome refers to a group of disease risk factors such as central obesity, type 2 diabetes or impaired glucose tolerance, hypertension, abnormal lipid metabolism and insulin resistance (IR). Clinical syndrome. In recent years, the metabolic syndrome has a high incidence and a younger trend, and its prominent features are obesity, insulin resistance and impaired glucose tolerance. In addition to its rich fibrous content, Phyllostachys pubescens contains a variety of biologically active substances unique to bamboo leaves. It has strong anti-free radical and anti-oxidant activities, and can also reduce inflammation, lipid-lowering and protect cardiovascular and cerebrovascular diseases. efficacy. Matcha is also rich in bioactive ingredients (such as tea polyphenols, tea polysaccharides, theanine, etc.), and many studies have shown that it can effectively prevent obesity and stroke, and reduce the risk of cerebral thrombosis and hyperlipidemia.
- bioactive ingredients such as tea polyphenols, tea polysaccharides, theanine, etc.
- the invention is represented by two kinds of sorrel bamboos (Bitter Bamboo - Wisdom bamboo and Cold Arrow bamboo -fulness bamboo), and a comparatively experimental study is carried out using a mouse model of metabolic syndrome with reference to a commercially available first-grade matcha.
- the rag and matcha were added to the high fat diet of the mice in a certain proportion.
- the four experimental groups were as follows: the first group was 2.5% of bitter bamboo - rag bamboo + high fat feed, the second group was 5.0% bitter bamboo - rag bamboo + high fat feed, and the third group was 2.5% cold arrow bamboo - rag bamboo + High fat diet, the fourth group is 2.5% matcha + high fat feed.
- mice Sixty 6-week-old C57BL/6J male mice were fed with basic diet for 5 days, and those who had no adverse reactions, ie, eating, drinking, and normal activities, were included in the experiment.
- the mice were randomly divided into 6 groups to ensure that the average body weight of each group was close, and the following feeds were fed separately: basic feed, high fat feed, bitter bamboo-salt low dose group, bitter bamboo-salt high dose group, cold arrow bamboo-salt low Dosage group and matcha low dose group.
- every 5 mice were caged, and they were given free access to drinking water in a feeding environment with a light cycle of 12 h, a temperature of 23 ⁇ 2 ° C, and a relative humidity of 50 to 70%.
- the test period was 12 weeks.
- the test grouping of mice is shown in Table 12.
- Group code 1 Basic feed control group 10 Bas-C 2 High fat diet control group 10 HFD 3 High fat feed + 2.5% bitter bamboo - rag 10 2.5% BP1-HFD 4 High fat feed +5.0% bitter bamboo - rag 10 5.0%BP1-HFD 5 High fat feed + 2.5% cold arrow bamboo - rag 10 2.5% BP2-HFD 6 High fat diet + 2.5% Matcha 10 2.5% M-HFD
- BP1 is the Phyllostachys pubescens obtained in Example 1.5; BP2 is the cold arrow bamboo stalk prepared in Example 1.6.
- mice During the feeding period, the general condition, dietary changes, behavior (autonomous activities, mental state) changes, and hair changes of the mice were observed every day. Mice were weighed once a week and changes in body weight were recorded. After 12 weeks of feeding, the liver, kidney, and spleen of the mice were carefully weighed and the visceral specific gravity coefficient was calculated. At the same time, the epididymal fat and perirenal fat were taken out and weighed. All organs were then stored at -80 °C.
- mice After 12 weeks of feeding, the mice were euthanized in a CO 2- filled incubator, and then blood was quickly taken from the heart, and serum was collected by centrifugation (3500 r/min, 15 min) for detection of triglyceride (TG), total Cholesterol (TC), low density lipoprotein cholesterol (LDL-c), high density lipoprotein cholesterol (HDL-c), free fatty acid (FFA) and other indicators.
- TG triglyceride
- TC total Cholesterol
- LDL-c low density lipoprotein cholesterol
- HDL-c high density lipoprotein cholesterol
- FFA free fatty acid
- mice were fasted for 12 hours (without water), and then blood was drawn using Roche blood glucose meter to detect the fasting blood glucose (FBG) value of the mice, and the enzyme-linked immunosorbent assay kit was used to determine the small amount.
- FBG fasting blood glucose
- FINS Fasting insulin
- mice were intraperitoneally injected with 0.75 U/Kg ⁇ BW of an insulin physiological saline solution (concentration: 0.075 U/mL). The blood glucose levels of the mice were then tested and recorded at 30, 60, 90, and 120 minutes after injection. The mice were fed back after the test.
- mice were quickly removed from the liver after euthanasia.
- the blood was washed away as much as possible, blotted dry, weighed and a small portion was added with 4 °C physiological saline high-speed homogenate to make a 10% homogenate, centrifuged at 3000 r/min for 20 min to take the supernatant.
- the solution was then used to determine the activity of SOD, GSH-Px and MDA in liver homogenate using a kit produced by Nanjing Institute of Bioengineering.
- IL-6 Serum interleukin-6
- TNF- ⁇ tumor necrosis factor- ⁇
- MCP-1 chemokine
- Leptin, adiponectin (ADPN) and lipopolysaccharide (LPS) in mouse serum were detected by enzyme-linked immunosorbent assay, and the detection method was carried out by referring to the Elisa kit method.
- the colonic feces of the mice were taken for 12 weeks, and high-throughput sequencing was performed. Illumina PE250 sequencing was used to extract the intestinal microbial DNA from the feces, followed by PCR amplification, and finally the intestinal microbial species were identified by sequencing.
- mice The weight gain of the mice, the index of each organ and the blood biochemical indicators were used to evaluate the efficacy of Phyllostachys pubescens and Matcha to lose weight and reduce fat.
- mice in the high-fat diet model group showed obesity characteristics.
- the weight gain of the mice in the basal diet group was significantly lower than that in the high-fat diet group.
- the effect of the broiler and matcha in the diet on body weight is shown in Fig. 5.
- the third group (high fat diet + 2.5% bitter bamboo - rag bamboo) had the best control effect on the body weight of mice.
- the average body weight of the mice was significantly lower than that of the high fat group;
- the addition of bitter bamboo-scented bamboo increased to 5% (fourth group), but the effect of controlling body weight was not obvious.
- the control effect of the sixth group (high-fat diet + 2.5% Matcha) on the weight of mice was second only to the same dose of bitter bamboo-scented bamboo.
- the average body weight at the end of the experiment was also significantly lower than that in the high-fat group.
- the weight loss effect of the fifth group (high-fat diet + 2.5% cold arrow bamboo - rag bamboo) was between the same dose of bitter bamboo - rag bamboo (third group) and matcha (the sixth group).
- the perirenal fat of mice in 2.5% bitter bamboo-Muzhu group is significantly lower than that in high fat group, which is obviously better than other three.
- Test group. 2.5% bitter bamboo - smudge bamboo and 2.5% cold arrow bamboo - smear bamboo have the effect of reducing epididymal fat, of which the effect of bitter bamboo is better, reducing the epididymal fat of mice by nearly half.
- mice serum was taken to test blood biochemical indicators including triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-c), high density lipoprotein cholesterol (HDL-c), Free fatty acids (FFA), and the results are shown in Table 13.
- TG triglyceride
- TC total cholesterol
- LDL-c low density lipoprotein cholesterol
- HDL-c high density lipoprotein cholesterol
- FFA Free fatty acids
- the high-fat diet leads to obesity in mice, and the accumulation of fat in obese mice increases, and it also causes an increase in the levels of TG, TC, LDL-c and FFA in the blood, and a certain degree of HDL-c reduction. It can be seen from Table 13 that Matcha has the best effect of reducing TG. After 3 months of dietary enhancement for 2.5%, the TG level of high-fat mice is close to the normal feed group; The most significant effect of reducing TC was to strengthen the 2.5% bitter bamboo-smoke group, while the 5.0% bitter bamboo-smoked bamboo and 2.5% cold arrow bamboo-smoked bamboo had no effect on TC, while the 2.5% matcha group TC was significantly higher than high fat. Model group.
- the performance group significantly improved the effect of 2.5% bitter bamboo - rag, followed by 2.5% matcha, followed by 2.5% cold arrow bamboo - rag.
- Free fatty acids are significantly increased in obese mice due to an imbalance in glycolipid metabolism.
- the data in Table 13 showed that all the test groups inhibited the increase in FFA levels, with the best effect being 2.5% Matcha, followed by 2.5% Bitter Bamboo and Cold Arrow Bamboo, and finally 5.0% Bitter Bamboo - bamboo. Once again proved that the amount of 2.5% of the additive is a reasonable level.
- the lipid-lowering effect was 2.5% of the bitter bamboo - rags, followed by 2.5% of matcha.
- the high-fat diet leads to an increase in fasting blood glucose (FBG) and fasting insulin (FINS) in mice, and HOME-IR is the insulin resistance index.
- FBG fasting blood glucose
- FINS fasting insulin
- HOME-IR is the insulin resistance index.
- 2.5% bitter bamboo - rag bamboo and 2.5% cold arrow bamboo - rag bamboo can better improve the insulin resistance caused by high-fat diet, and reduce the fasting insulin level in mice.
- 5.0% bitter bamboo - sorrel and matcha group did not significantly improve.
- Figure 7 shows changes in mouse insulin sensitivity at the end of the trial, A is the insulin tolerance test (ITT) and B is the glucose tolerance test (GTT).
- ITT insulin tolerance test
- GTT glucose tolerance test
- SOD and GSH-Px in the liver are the main antioxidant enzymes in the body and have strong ability to scavenge free radicals.
- the data in Table 15 showed that the SOD levels of the high-fat group, 5.0% bitter bamboo-wiat bamboo and 2.5% matcha group were significantly higher than those of the normal group, while 2.5% of the bamboos of the bamboo, the bamboo and the cold bamboo The SOD activity is comparable to the normal group.
- GSH-Px level 2.5% of the Phyllostachys pubescens - Phyllostachys praecox and the cold arrow bamboo - rag bamboo were between the normal group and the high fat group, while the 5.0% bitter bamboo - rag bamboo and 2.5% matcha group were significantly higher than the high.
- Lipid group From the perspective of reducing the level of lipid peroxide products, the effect of rags is generally better than that of matcha, and bitter bamboo is preferred.
- Oxidative stress is caused by a large amount of reactive oxygen species (ROS) in the body after being stimulated by various harmful factors.
- ROS reactive oxygen species
- the compensatory increase in the activity of antioxidant enzymes cannot prevent free radical damage, which will eventually lead to a decrease in enzyme activity and an increase in oxidative damage.
- the high-fat diet increased the degree of oxidative stress in the mouse body.
- the dietary intervention of Phyllostachys pubescens could effectively reduce the oxidative stress response of the body, and the 2.5% rag additive was preferred.
- MCP-1 is a chemokine.
- MCP-1 a chemokine.
- the enlarged adipose tissue in obese people releases a large amount of MCP-1, which induces a large number of phagocytic cells to enter adipose tissue and release a large number of inflammatory factors.
- IL-6 and TNF- ⁇ are two pro-inflammatory factors closely related to obesity. When the levels of the two are increased, it indicates that the degree of inflammatory infiltration of the body is increased.
- the levels of TNF- ⁇ and MCP-1 in the high-fat group were significantly higher than those in the normal group, indicating that there was inflammation in the obese mice in the high-fat group.
- the high-fat mice added with bitter bamboo-scented bamboo, scutellaria chinensis-scented bamboo and matcha had significantly decreased TNF- ⁇ content, indicating that different doses of Phyllostachys pubescens and Matcha could significantly inhibit the pro-inflammatory factors caused by obesity (TNF- The secretion of ⁇ ). 2.5% added amount of bitter bamboo - rag bamboo, cold arrow bamboo - rag and matcha can significantly reduce the content of MCP-1, while the high dose (5.0% bitter bamboo - rag bamboo) failed to significantly reduce its content.
- the results showed that dietary intervention with appropriate doses of rags and matcha can significantly improve the inflammatory infiltration in obese mice.
- Leptin is a circulating hormone secreted by fat cells, which acts mainly on the central nervous system. By inhibiting the synthesis of neuropeptide Y, it reduces appetite and reduces energy intake, thereby achieving the effect of reducing weight and reducing fat. Studies have shown that too high or too low leptin may lead to insulin resistance (IR). The data in Table 16 showed that serum leptin levels in the high-fat group were significantly higher than those in the normal group, indicating that the high-fat diet produced leptin resistance in the mice.
- the 2.5% added amount of bitter bamboo - sorrel showed the best effect of reducing serum leptin levels in mice, followed by 2.5% Matcha, followed by 2.5% of cold arrow bamboo - rag, and 5% added bitter bamboo -
- the effect of smearing bamboo is not significant.
- Adiponectin is closely related to obesity and glycolipid metabolism. Studies have shown that ADP levels are significantly lower in obese people, and adiponectin levels are negatively correlated with obesity. From the data in Table 16, the adiponectin content of the high-fat group mice was significantly lower than that of the normal group, and the four test groups of Phyllostachys pubescens and Matcha showed significant effects on increasing serum ADP levels in high-fat mice. It is better to add 2.5% of the bitter bamboo - sorrel and matcha, and the ADP after intervention is close to the normal group of mice.
- Lipopolysaccharide is mainly produced by cleavage of Gram-negative bacteria in the intestine. Studies have shown that lipopolysaccharide is closely related to the up-regulation of inflammatory factors in obese mice.
- the data in Table 16 showed that the lipopolysaccharide content of the high-fat group was significantly higher than that of the normal group.
- the test group with the addition of rag and matcha in the high-fat diet significantly reduced the level of lipopolysaccharide in the serum of obese mice, and 2.5% bitter bamboo.
- the effect of rags is extremely significant, and the LPS values of this group of mice are significantly lower than those of the normal group. It indicated that the dietary intervention of rag and matcha can significantly improve the secretion of intracellular factors caused by high-fat diet.
- Figure 9 is a H&E stained section of liver tissue from different groups of mice. It can be seen that there are many white lipid droplets of different sizes in the liver section of the high-fat model group (B) compared with the normal group (A) mice, indicating that the high-fat diet causes liver lipid metabolism. Obstacles, the large amount of fat ingested cannot be broken down smoothly and gradually deposited in the liver. The number of liver lipid droplets in the high-fat diet group (C, D, E) and the high-fat diet group (F) added with Matcha was significantly lower than that in the high-fat model group, and no large white color was observed. Lipid drops. It shows that both rag and matcha can significantly improve the lipid metabolism of the liver and reduce the risk of fatty liver caused by high-fat diet.
- Figure 10 is a H&E stained section of the epididymal adipose tissue of different groups of mice (200 ⁇ ), 100 ⁇ m; among them, A to E represent the normal group, the high-fat group, the 2.5% bitter bamboo + high-fat group, and 5.0% bitter bamboo.
- the high fat model group (B) mice have a significantly larger volume of fat cells than the normal group (A) due to long-term feeding of high fat diet. After the diet was intensively smeared with Matcha and Matcha, the fat cells in the epididymis showed a significant decrease trend, and the most significant was 2.5% of the bitter bamboo-Mathu group.
- the normal group, the high-fat model group, the 2.5% added amount of rag and the matcha test group were selected and analyzed by high-throughput sequencing technology.
- the intestinal flora structure of the mouse the results are shown in Figure 11, in each column, from bottom to top, followed by Firmicutes, Bacteroidetes, Actinobacteria, and deformation. Proteobacteria and Verrucomicrobia.
- the OTUs of intestinal microbes of different groups of experimental mice were obtained by high-throughput sequencing. After the gene library comparison and species annotation, the OUTs of the tested mice belonged to the following nine gates: Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Deferribacteres, Verrucomicrobia, Cyanobacteria, Tenericutes ) and Saccharibacteria. Among them, the five doors of Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, and Verrucomicrobia are shared by all groups.
- the F/B value of the mice in the group was significantly reduced to 2.82, indicating that it has a good regulatory effect on the intestinal flora structure of mice, which can correct the adverse effects caused by the high-fat diet; and 2.5% of the cold arrow bamboo-wipe bamboo and 2.5% of Matcha did not show this effect.
- the F/B values of the two experimental groups did not decrease, and were 12.60 and 9.25, respectively.
- mice Twenty healthy ICR mice with a body weight of 18 to 22 g, 10 males and 10 females, were selected.
- a dose group of 20.0 g/kg.BW was set according to the limit method. Weigh 20g of Phyllostachys pubescens L. and prepare a 40mL sample solution using 1% sodium carboxymethylcellulose as a solvent. The mice were fasted (without water) for 6 hours before the gavage, and were intragastrically administered with a perfusion volume of 20 mL/kg. BW. The rats were intragastrically administered twice with an interval of 4 hours. After 3 hours of oral administration, they were free to eat and drink, and recorded animal poisoning performance and death. The observation period was 14 days, and the mice were recorded at the beginning and end of the experiment. The results are shown in Table 17.
- bitter bamboo - smudge bamboo as raw material, according to the raw material formula of Table 20 to make rag cookies.
- the bitter bamboo-sorrel was used for the production of nougat, and the formulation was as shown in Table 22, and the preparation method was referred to the conventional technique.
- the sirloin nougat scored the highest, followed by the original nougat, and finally the matcha nougat; in terms of tissue status, the sorrel nougat score was slightly higher than the other two.
- the scores of the original taste and the scented bamboo taste are very close, which are higher than the matcha taste.
- the original nougat score is slightly higher than the other two. Due to the bitter taste of the matcha, it is difficult for some testers to accept .
- the bitter bamboo-sorrel was used for the preparation of the sauce, and the formulation is shown in Table 23.
- the light bamboo-sorrel was used for the production of solid beverages, and the formulation is shown in Table 24.
- the light bamboo-sorrel was used for the production of solid beverages, and the formulation is shown in Table 25.
- the bitter bamboo-sorrel was used for the preparation of the seasoning salt, and the formulation is shown in Table 26.
- Example 5 The regulation of human lipid metabolism and the prevention and treatment of osteoporosis as a dietary supplement (solid beverage)
- Example 1.6 The bitter bamboo-sorrel obtained in Example 1.6 is divided into small packages of 4g/bag, washed with warm water, or added to milk, honey and stirred for delivery. Take a bag every day in the afternoon and afternoon.
- the data in Table 28 shows that rags has a significant regulatory effect on the body fat and blood lipids of the subject.
- the weight loss of the 16 subjects was between 0.7 and 4.5 kg; the waist circumference of all the subjects was reduced (2 to 4 cm), indicating that the bamboo has a certain effect on the reduction of centripetal fat in obese patients.
- the TG, TC and LDL-c levels of most of the subjects showed a downward trend, and the abnormal serum TG and TC indexes of 1 # , 2 # and 14 # after 3 months of trials all returned to normal levels; 7 # , 9 # , 10 # significantly decreased.
- the invention adopts fresh bamboo leaves as raw materials, adopts unique processing technology, and creates an ultra-fine powder with excellent green color, fragrant scent and uniform fineness, which is called rag bamboo, has the processing suitability and health effect close to matcha, and is human.
- the society provides a new type of food functional ingredient and/or dietary supplement that is natural, green, rich in bamboo leaf chemicals and dietary fiber.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
Abstract
Description
序号 | 组别 | 数量(n) | 组别代号 |
1 | 基础饲料对照组 | 10 | Bas-C |
2 | 高脂饲料对照组 | 10 | HFD |
3 | 高脂饲料+2.5%苦竹-抹竹 | 10 | 2.5%BP1-HFD |
4 | 高脂饲料+5.0%苦竹-抹竹 | 10 | 5.0%BP1-HFD |
5 | 高脂饲料+2.5%冷箭竹-抹竹 | 10 | 2.5%BP2-HFD |
6 | 高脂饲料+2.5%抹茶 | 10 | 2.5%M-HFD |
Claims (17)
- 抹竹,其特征是:所述抹竹是以禾本科(Graminae)、竹亚科(Bambusoideae)植物的叶片为原料制备的,具有稳定的翠绿色泽,粉体平均粒径在800~10,000目之间;膳食纤维总量≥60%、木质素含量≥20%、矿物质≥7%;并至少含有3种及以上的竹叶特征性成分;所述竹叶特征性成分为荭草苷、异荭草苷、牡荆苷、异牡荆苷、腺苷、δ-羟基赖氨酸、对香豆酸。
- 如权利要求1所述的抹竹,其特征是:所述具有稳定的翠绿色泽是指,所述抹竹的色值在L*为46~60之间,△a*为-16~-8之间。
- 如权利要求1所述的抹竹,其特征是:所述具有稳定的翠绿色泽是指,所述抹竹在180℃的高温下烘烤30min后,色值的L*仍保持在40~50之间,△a*仍在-7~-5之间。
- 如权利要求1所述的抹竹,其特征是:所述具有稳定的翠绿色泽是指,所述抹竹在紫外线照射180min后,其色值的△a*仍保持在-6~-3之间。
- 如权利要求2所述的抹竹,其特征是:所述具有稳定的翠绿色泽是指,所述抹竹的色值在L*为47~59之间,△a*为-15~-9之间。
- 如权利要求1所述的抹竹,其特征是:所述原料来源为淡竹[Phyllostachys nigra var.Hnonis(Bean)Stepf ex Rendle]、浙江淡竹(Phyllostachys meyeri McClure)、毛竹(Phyllostachys heterocycla var.pubescens(Mazel)Ohwi)、慈竹(N.affinis(Rendle)Keng f.)、绵竹(B.intermedia Hsueh et Yi)、硫玉竹(Yushania Keng f.)、苦竹(P.amarus(keng)Keng f.)、冷箭竹(B.fangiana Keng f.et Wen)、黄条金刚竹(Pleioblastus kongosanensis f.aureostriaus)、青氏赤竹(Sasa tsuboiana)和美丽箬竹(Indocalamus decorus)的鲜叶。
- 抹竹的制备方法,其特征是:将原料依次进行烫漂护色、干燥、超微粉碎;得平均粒径为800~10,000目的抹竹;所述原料为禾本科(Graminae)、竹亚科(Bambusoideae)植物的叶片;所述烫漂护色步骤为:将作为原料的竹叶放入温度为80~100℃的护色液中,浸泡后捞出,沥干;所述烫漂护色中所采用的护色液为浓度0.5~2.0g/100mL的硫酸锌水溶液或葡萄糖酸锌水溶液或其组合。
- 根据权利要求7所述的抹竹的制备方法,其特征是:所述烫漂护色步骤为:将作为原料的竹叶放入温度为85~95℃的护色液中,浸泡30~90s后捞出,沥干;竹叶与护色液的料液比为1g:50~100mL。
- 根据权利要求7所述的抹竹的制备方法,其特征是:所述干燥为:将烫漂护色处理后的叶片干燥至含水率≤11%;所述干燥采用热风干燥、微波干燥、真空干燥、冷冻干燥中的至少一种或其组合。
- 根据权利要求7所述的抹竹的制备方法,其特征是:在超微粉碎前进一步将烫漂护色处理后的叶片干燥至含水率≤10%。
- 根据权利要求7所述的抹竹的制备方法,其特征是:在超微粉碎前进一步将烫漂护色处理后的叶片干燥至含水率≤7%。
- 根据权利要求7所述的抹竹的制备方法,其特征是:超微粉碎将 干燥后的叶片粉碎至平均粒径为1,000~3,000目。
- 根据权利要求7所述的抹竹的制备方法,其特征是:超微粉碎将干燥后的叶片粉碎至平均粒径为1,500~2,500目。
- 根据权利要求7所述的抹竹的制备方法,其特征是:所述原料来源为淡竹[Phyllostachys nigra var.Hnonis(Bean)Stepf ex Rendle]、浙江淡竹(Phyllostachys meyeri McClure)、毛竹(Phyllostachys heterocycla var.pubescens(Mazel)Ohwi)、慈竹(N.affinis(Rendle)Keng f.)、绵竹(B.intermedia Hsueh et Yi)、硫玉竹(Yushania Keng f.)、苦竹(P.amarus(keng)Keng f.)、冷箭竹(B.fangiana Keng f.et Wen)、黄条金刚竹(Pleioblastus kongosanensis f.aureostriaus)、青氏赤竹(Sasa tsuboiana)和美丽箬竹(Indocalamus decorus)的鲜叶。
- 根据权利要求7所述的抹竹的制备方法,其特征是:所述超微粉碎采用高能纳米冲击球磨,磨球选用锆球,球料比为10:1;或者,所述超微粉碎也可采用气流粉碎;或者,所述超微粉碎也可采用气流粉碎+高能纳米冲击球磨。
- 如权利要求7~15任一所述制备而得的抹竹的用途,其特征是:利用抹竹的热稳定性和光稳定性将其作为食品原料、功能性配料,或者作为膳食补充剂;以干物质计,抹竹在食品体系中的添加量为1~10%。
- 根据权利要求16所述的抹竹的用途,其特征是为以下任一:稳定的天然绿色素;补充人体膳食纤维、改善肠胃道功能,有助于控制体重和预防便秘;改善和调节肠道菌群,提高人体对胰岛素的敏感性,防治胰岛素抵抗, 预防代谢综合征;有助于改善人体微循环,有效保护心脑血管;有助于调节糖脂代谢和能量代谢,防治代谢综合症;有助于防止骨质疏松,保持皮肤年轻态,延缓人体衰老。
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310972724.1A CN117441810A (zh) | 2017-10-25 | 2018-10-24 | 抹竹及其制备方法和用途 |
EP18870333.4A EP3701809A4 (en) | 2017-10-25 | 2018-10-24 | FINE BAMBOO POWDER AND ASSOCIATED PREPARATION PROCESS, AND CORRESPONDING USE |
JP2020543677A JP7054736B2 (ja) | 2017-10-25 | 2018-10-24 | 竹の粉末およびその製造方法と使用 |
US16/759,574 US11278585B2 (en) | 2017-10-25 | 2018-10-24 | Method for preparing fine bamboo powder |
CN201880069981.1A CN111655048B (zh) | 2017-10-25 | 2018-10-24 | 抹竹及其制备方法和用途 |
KR1020207014928A KR102459017B1 (ko) | 2017-10-25 | 2018-10-24 | 고급 대나무 분말 및 이의 제조방법과 용도 |
US17/589,963 US20220226418A1 (en) | 2017-10-25 | 2022-02-01 | Fine bamboo powder and preparation method therefor and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711004411.8 | 2017-10-25 | ||
CN201711004411.8A CN107811301A (zh) | 2016-10-25 | 2017-10-25 | 抹竹及其制备方法和用途 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/759,574 A-371-Of-International US11278585B2 (en) | 2017-10-25 | 2018-10-24 | Method for preparing fine bamboo powder |
US17/589,963 Division US20220226418A1 (en) | 2017-10-25 | 2022-02-01 | Fine bamboo powder and preparation method therefor and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019080848A1 true WO2019080848A1 (zh) | 2019-05-02 |
Family
ID=88405018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/111523 WO2019080848A1 (zh) | 2017-10-25 | 2018-10-24 | 抹竹及其制备方法和用途 |
Country Status (6)
Country | Link |
---|---|
US (2) | US11278585B2 (zh) |
EP (1) | EP3701809A4 (zh) |
JP (1) | JP7054736B2 (zh) |
KR (1) | KR102459017B1 (zh) |
CN (2) | CN111655048B (zh) |
WO (1) | WO2019080848A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021008430A (ja) * | 2019-07-01 | 2021-01-28 | インプレッション株式会社 | 健康増進用組成物、及び当該健康増進用組成物を含む医薬品又は飲食品 |
WO2021081305A1 (en) * | 2019-10-25 | 2021-04-29 | Tate & Lyle Ingredients Americas Llc | Soluble dietary fiber and methods of making and use thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102600785B1 (ko) * | 2021-01-28 | 2023-11-10 | 연세대학교 산학협력단 | 페놀산 유도체를 유효성분으로 포함하는 식욕 억제용 조성물 |
CN115067461A (zh) * | 2022-06-17 | 2022-09-20 | 浙江古茗科技有限公司 | 食品着色组合物、糯米丸子的制备方法及糯米丸子 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528197A (zh) * | 2003-10-08 | 2004-09-15 | ƽ | 竹叶抗氧化物及其用途 |
CN101049120A (zh) * | 2006-04-07 | 2007-10-10 | 河南工业大学 | 全天然速溶绿茶的制备方法 |
CN102187926A (zh) * | 2011-02-25 | 2011-09-21 | 河北科技师范学院 | 一种山楂核抹茶、山楂核饮料的加工工艺 |
CN107811301A (zh) * | 2016-10-25 | 2018-03-20 | 杭州凝竹生物科技有限公司 | 抹竹及其制备方法和用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2872971B2 (ja) * | 1996-07-04 | 1999-03-24 | 仁一 冨士谷 | 植物の緑色を復元しあるいは緑色に保持する方法 |
KR100839029B1 (ko) | 2005-07-20 | 2008-06-19 | 담양군 | 죽엽 분말의 제조 방법 |
CN100574645C (zh) | 2006-10-25 | 2009-12-30 | 浙江大学 | 一种食用竹粉的制备方法 |
JP4933572B2 (ja) | 2009-02-18 | 2012-05-16 | 精一 杉山 | 竹粉を用いた醗酵食品の製造方法及び醗酵食品 |
JP2011057658A (ja) | 2009-09-08 | 2011-03-24 | Cosme Techno:Kk | 化粧料 |
CN102246963A (zh) * | 2010-05-17 | 2011-11-23 | 上海朝翔生物技术有限公司 | 一种竹叶提取物添加剂及其制备方法 |
CN101973984B (zh) * | 2010-10-13 | 2012-07-04 | 南方医科大学 | 一种提取竹叶总黄酮的方法 |
CN102715470B (zh) * | 2011-07-05 | 2013-06-05 | 宁国市乡味源农产品开发有限公司 | 一种竹笋超微粉的制备方法 |
CN103734413B (zh) * | 2013-12-19 | 2015-07-29 | 青岛海大生物集团有限公司 | 一种绿藻茶及其制备方法 |
WO2015109299A2 (en) * | 2014-01-20 | 2015-07-23 | Hangzhou Bamdion Biotech Co. Ltd. | Bamboo extracts, compositions and uses thereof |
JP6480204B2 (ja) | 2015-02-04 | 2019-03-06 | 株式会社 伊藤園 | 緑色系飲料及びその製造方法 |
CN104738248B (zh) * | 2015-04-01 | 2018-01-16 | 统一企业(中国)投资有限公司昆山研究开发中心 | 含悬浮抹茶粉颗粒的奶茶饮料及其制作方法 |
CN105533589A (zh) * | 2015-12-11 | 2016-05-04 | 重庆市林业科学研究院 | 豆腐柴叶膏及其制备方法 |
CN106579467A (zh) | 2016-11-22 | 2017-04-26 | 浙江科技学院 | 一种竹叶膳食纤维的制备方法 |
-
2018
- 2018-10-24 WO PCT/CN2018/111523 patent/WO2019080848A1/zh unknown
- 2018-10-24 KR KR1020207014928A patent/KR102459017B1/ko active IP Right Grant
- 2018-10-24 JP JP2020543677A patent/JP7054736B2/ja active Active
- 2018-10-24 EP EP18870333.4A patent/EP3701809A4/en active Pending
- 2018-10-24 US US16/759,574 patent/US11278585B2/en active Active
- 2018-10-24 CN CN201880069981.1A patent/CN111655048B/zh active Active
- 2018-10-24 CN CN202310972724.1A patent/CN117441810A/zh active Pending
-
2022
- 2022-02-01 US US17/589,963 patent/US20220226418A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528197A (zh) * | 2003-10-08 | 2004-09-15 | ƽ | 竹叶抗氧化物及其用途 |
CN101049120A (zh) * | 2006-04-07 | 2007-10-10 | 河南工业大学 | 全天然速溶绿茶的制备方法 |
CN102187926A (zh) * | 2011-02-25 | 2011-09-21 | 河北科技师范学院 | 一种山楂核抹茶、山楂核饮料的加工工艺 |
CN107811301A (zh) * | 2016-10-25 | 2018-03-20 | 杭州凝竹生物科技有限公司 | 抹竹及其制备方法和用途 |
Non-Patent Citations (2)
Title |
---|
"Testing Methods for Effective Ingredients of Health Foods", 2002, CHINA LIGHT INDUSTRY PRESS, pages: 29 - 31 |
GONG JINYAN ET AL.: "HPLC Method for determination of adenosine content in bamboo shavings extract and its different parts", FOOD INDUSTRY, vol. 35, no. 12, 2014, pages 264 - 265 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021008430A (ja) * | 2019-07-01 | 2021-01-28 | インプレッション株式会社 | 健康増進用組成物、及び当該健康増進用組成物を含む医薬品又は飲食品 |
WO2021081305A1 (en) * | 2019-10-25 | 2021-04-29 | Tate & Lyle Ingredients Americas Llc | Soluble dietary fiber and methods of making and use thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20200074985A (ko) | 2020-06-25 |
EP3701809A1 (en) | 2020-09-02 |
EP3701809A4 (en) | 2021-07-28 |
KR102459017B1 (ko) | 2022-10-26 |
US20220226418A1 (en) | 2022-07-21 |
CN117441810A (zh) | 2024-01-26 |
CN111655048A (zh) | 2020-09-11 |
CN111655048B (zh) | 2023-08-04 |
US11278585B2 (en) | 2022-03-22 |
JP7054736B2 (ja) | 2022-04-14 |
US20210177927A1 (en) | 2021-06-17 |
JP2021500410A (ja) | 2021-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106234926B (zh) | 富硒五谷营养速溶粉及其制备方法 | |
US20220226418A1 (en) | Fine bamboo powder and preparation method therefor and use thereof | |
CN102242070B (zh) | 一种蝉拟青霉人工培养的方法及其培养产物的应用 | |
KR102076459B1 (ko) | 갈색거저리 효소처리물을 함유하는 회복기 환자 또는 노약자의 근육량 증강 및 원기회복용 조성물 | |
CN101449689A (zh) | 一种桑叶营养曲奇及其制作方法 | |
CN103039658A (zh) | 一种柿子叶、甜茶叶茶及其制备方法 | |
CN106035900A (zh) | 一种姜茶及其制备方法 | |
CN103719944A (zh) | 一种以黑麦为基础的食疗养生粉及其制备方法 | |
CN100444746C (zh) | 一种高寒山区作物精制健康食品及其加工工艺 | |
CN104472612A (zh) | 能够调理肠胃的面包所用天然酵母面包预拌粉 | |
CN107981208A (zh) | 一种牛蒡减肥食品及其制备方法 | |
KR101030035B1 (ko) | 스피루리나를 함유하는 쌀엿강정 및 그 제조방법 | |
CN107811301A (zh) | 抹竹及其制备方法和用途 | |
CN100452989C (zh) | 一种以蔬菜和/或水果为原料的食品制剂及其制备方法 | |
KR100855665B1 (ko) | 감과 한약재 조성물을 함유한 항콜레스테롤용 고추장 및 그제조방법 | |
CN106213413A (zh) | 芝麻花生酱 | |
CN101396056B (zh) | 松针茯苓茶及其制备方法 | |
CN106967578A (zh) | 一种核桃粕糯米营养醋粉的制备方法 | |
CN104116070A (zh) | 一种具有保健作用的富硒有机绿茶养生酥饼及其制法 | |
CN105831636A (zh) | 一种猕猴桃维生素c咀嚼片及其制作方法 | |
CN106036442A (zh) | 一种绿色健康蛋糕 | |
CN107509838A (zh) | 一种发酵型黑米茶的制备方法 | |
CN104432061A (zh) | 生物胚胎细胞营养素 | |
KR20150064521A (ko) | 죽염 및 쥐눈이콩을 포함하는 발효조성물 | |
Sukha | Potential value added products from Trinidad and Tobago cocoa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18870333 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2020543677 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207014928 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018870333 Country of ref document: EP Effective date: 20200525 |